Publication Results (59)

• «
• 1
• 2
• »

• Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study

  Antoniou T, McCormack D, Kitchen S, Pajer K, Gardner W, Lunsky Y, Penner M, Tadrous M, Mamdani M, Juurlink DN, Gomes T. BMC Public Health. 2023; 23(1):85. Epub 2023 Jan 11. DOI: https://doi.org/10.1186/s12889-022-14677-6

• Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario

  Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. CMAJ. 2022; 194(36):E1233-42. Epub 2022 Sep 19. DOI: https://doi.org/10.1503/cmaj.220892

• The burden of cancer among people living with HIV in Ontario, Canada, 1997-2020: a retrospective population-based cohort study using administrative health data

  Nicolau IA, Antoniou T, Brooks JD, Moineddin R, Cooper C, Cotterchio M, Gillis JL, Kendall CE, Kroch AE, Lindsay JD, Price C, Salters K, Smieja M, Burchell AN. CMAJ Open. 2022; 10(3):E666-74. Epub 2022 Jul 19. DOI: https://doi.org/10.9778/cmajo.20220012

• Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study

  Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109473

• Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

  Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109459

• The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

  Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11. DOI: https://doi.org/10.3389/fphar.2022.861953

• Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

  Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B. Addiction. 2022; 117(7):1972-81. Epub 2022 Mar 8. DOI: https://doi.org/10.1111/add.15862

• Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

  Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J. JAMA. 2022; 327(9):846-55. Epub 2022 Mar 1. DOI: https://doi.org/10.1001/jama.2022.1271

• Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

  Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Int J Drug Policy. 2022; 103:103644. Epub 2022 Mar 1. DOI: https://doi.org/10.1016/j.drugpo.2022.103644

• Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada

  Young S, Koll G, McCormack D, Campbell T, Leece P, Strike C, Srivastava A, Antoniou T, Bayoumi AM, Gomes T. Int J Drug Policy. 2022; 102:103601. Epub 2022 Feb 3. DOI: https://doi.org/10.1016/j.drugpo.2022.103601

• The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis

  Boone CG, Antoniou T, Juurlink DN, von den Baumen TR, Kitchen SA, Richards GC, Tadrous M, Gomes T. CMAJ Open. 2021; 9(4):E1181-6. Epub 2021 Dec 14. DOI: https://doi.org/10.9778/cmajo.20210173

• Health care utilization in medically complex people living with HIV before and after admission to an HIV-specific community facility: a pre-post comparison study

  Stewart A, Antoniou T, Graves E, Plumptre L, Carusone SC. CMAJ Open. 2021; 9(2):E460-5. Epub 2021 May 6. DOI: https://doi.org/10.9778/cmajo.20200024

• Herpes zoster in older adults in Ontario, 2002-2016: investigating incidence and exploring equity

  Buchan SA, Daneman N, Wang J, Wilson SE, Garber G, Wormsbecker AE, Antoniou T, Deeks SL. PLoS One. 2021; 16(2):e0246086. Epub 2021 Feb 11. DOI: https://doi.org/10.1371/journal.pone.0246086

• Impact of policy changes on the provision of naloxone by pharmacies in Ontario Canada: a population-based time series analysis

  Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, Mamdani M, Juurlink DN, Gomes T. Addiction. 2021; 116(6):1514-20. Epub 2020 Nov 18. DOI: https://doi.org/10.1111/add.15324

• Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: a population-based small area variation analysis

  Antoniou T, McCormack D, Campbell T, Sutradhar R, Tadrous M, Lum-Wilson N, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2020; 216:108238. Epub 2020 Aug 19. DOI: https://doi.org/10.1016/j.drugalcdep.2020.108238

• Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996–2015: a retrospective population-based cohort study

  Antoniou T, Yao Z, Raboud J, Gershon AS. CMAJ Open. 2020; 8(1):E83-9. Epub 2020 Feb 18. DOI: https://doi.org/10.9778/cmajo.20190028

• Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study

  Martins D, McCormack D, Tadrous M, Gomes T, Kwong JC, Mamdani MM, Buchan SA, Antoniou T. Clin Infect Dis. 2021; 72(2):279-84. Epub 2020 Jan 10. DOI: https://doi.org/10.1093/cid/ciaa014

• The uptake of the pharmacy-dispensed naloxone kit program in Ontario: a population-based study

  Choremis B, Campbell T, Tadrous M, Martins D, Antoniou T, Gomes T. PLoS One. 2019; 14(10):e0223589. Epub 2019 Oct 18. DOI: https://doi.org/10.1371/journal.pone.0223589

• Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide

  Mamdani M, Gomes T, Greaves S, Manji S, Juurlink DN, Tadrous M, Kennedy SH, Antoniou T. JAMA Netw Open. 2019; 2(10):e1913304. Epub 2019 Oct 16. DOI: 10.1001/jamanetworkopen.2019.13304.

• 90-90-90 for everyone? Access to HIV care and treatment for people with HIV who experience imprisonment in Ontario, Canada

  Kouyoumdjian FG, Lamarche L, McCormack D, Rowe J, Kiefer L, Kroch L, Antoniou T. AIDS Care. 2020; 32(9):1168-76. Epub 2019 Oct 15. DOI: https://doi.org/10.1080/09540121.2019.1679710

• A comparison of the observed and expected prevalence of HIV in persons released from Ontario provincial prisons in 2010

  Van Meer R, Antoniou T, McCormack D, Khanna S, Kendall C, Kiefer L, Kouyoumdjian FG. Can J Public Health. 2019; 110(5):675-82. Epub 2019 Jun 27. DOI: 10.17269/s41997-019-00233-0.

• Postpartum mental health service utilization in women with Human Immunodeficiency Virus (HIV): a population-based study

  Sparrow-Downes VM, Loutfy M, Antoniou T, Vigod SN. AIDS Care. 2019; 31(11):1332-9. Epub 2019 Apr 29. DOI: 10.1080/09540121.2019.1612007.

• Antiretroviral prescription pick-up and physician follow-up after hospital discharge among medically complex people with HIV

  Antoniou T, Graves E, Plumptre L, Stewart A, Carusone SC. Open Forum Infect Dis. 2019; 6(2):ofz009. Epub 2019 Jan 19.

• Health care utilization by people with HIV on release from provincial prison in Ontario, Canada in 2010: a retrospective cohort study

  Khanna S, Leah J, Fung K, Antoniou T, Kouyoumdjian F. AIDS Care. 2019; 31(7):785-92. Epub 2018 Dec 12.

• Pregabalin and the risk for opioid-related death: a nested case-control study

  Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN. Ann Intern Med. 2018; 169(10):732-4. Epub 2018 Aug 21.

• A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride

  Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. BMC Musculoskelet Disord. 2018; 19:160. Epub 2018 May 22.

• Outcomes among persons with HIV following a mental health admission: a population-based study

  Lau C, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Rourke S, Antoniou T. AIDS Res Hum Retroviruses. 2018; 34(7):590-7. Epub 2018 Apr 17.

• Assessing timely presentation to care among people diagnosed with HIV during hospital admission: a population-based study in Ontario, Canada

  Kendall CE, Shoemaker ES, Raboud J, Mark AE, Bayoumi AM, Burchell AN, Loutfy M, Rourke SB, Liddy CE, Rosenes R, Rogers T, Antoniou T. AIDS Behav. 2018; 22(8):2575-83. Epub 2018 Mar 13.

• Co-morbid non-communicable diseases and associated health service use in African and Caribbean immigrants with HIV

  Masindi KI, Jembere N, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Raboud J, Rourke SB, Luyombya H, Antoniou T. J Immigr Minor Health. 2018; 20(3):536-45. Epub 2017 Dec 5.

• Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: a population-based retrospective cohort study

  Burchell AN, Kendall CE, Cheng SY, Lofters A, Cotterchio M, Bayoumi AM, Glazier RH, Antoniou T, Raboud J, Yudin MH, Loutfy M. Prev Med. 2018; 107:14-20. Epub 2017 Nov 29.

• Mental health disorders and publicly funded service use by HIV positive individuals: a population-based cross-sectional study in Ontario, Canada

  Durbin A, Brown HK, Antoniou T, Sirotich F, Bansal S, Heifetz M, Roesslein K, Lunksy Y. AIDS Behav. 2017; 21(12):3457-63. Epub 2017 Nov 2.

• Gabapentin, opioids and the risk of opioid-related death: a population-based nested case-control study

  Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. PLoS Med. 2017; 14(10):e1002396. Epub 2017 Oct 3.

• A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada

  Kendall CE, Walmsley S, Lau C, Jembere N, Burchell AN, Loutfy M, Raboud J, Rosenes R, Rourke SB, Antoniou T. CMAJ Open. 2017; 5(3):E673-81. Epub 2017 Aug 30.

• Mortality and health service use following acute myocardial infarction among persons with HIV: a population-based study

  Jeon C, Lau C, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Rourke S, Antoniou T. AIDS Res Hum Retroviruses. 2017; 33(12):1214-9. Epub 2017 Aug 17.

• Pregabalin and heart failure: a population-based study

  Ho JM, Macdonald EM, Luo J, Gomes T, Antoniou T, Mamdani MM, Juurlink DN. Pharmacoepidemiol Drug Saf. 2017; 26(9):1087-92. Epub 2017 Jun 16.

• How HIV affects health and service use for adults with intellectual and developmental disabilities

  Durbin A, Brown HK, Bansal S, Antoniou T, Jung JKH, Lunsky Y. J Intellect Disabil Res. 2017; 61(7):682-696. Epub 2017 Jun 13.

• Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities

  Lunsky Y, Durbin A, Brown HK, Bansal S, Heifetz M, Antoniou T. AIDS. 2017; 31(5):697-705. Epub 2016 Nov 28.

• Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation

  Antoniou T, Macdonald EM, Yao Z, Hollands S. Gomes T, Tadrous M, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. CMAJ. 2017; 184(1):E4-10. Epub 2016 Nov 21.

• Varenicline and risk of self-harm: a nested case-control study

  Tadrous M, Martins D, Yao Z, Mamdani MM, Juurlink DN, Gomes T, Antoniou T. PLoS One. 2016; 11(9):e0163681.

• Emergency department use by people with HIV in Ontario: a population-based cohort study

  Ng R, Kendall CE, Burchell AN, Bayoumi AM, Loutfy MR, Raboud J, Glazier RH, Rourke S, Antoniou T. CMAJ Open. 2016; 4(2):E240-8. Epub 2016 May 25.

• «
• 1
• 2
• »